Selective acquired long QT syndrome (saLQTS) upon risperidone treatment

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Lazarczyk, Maciej J ^a   Bhuiyan, Zahir A ^b   Perrin, Nicolas ^a   Giannakopoulos, Panteleimon ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Acquired long QT syndrome; Antipsychotic; Clozapine; HERG; KCNH2; Long QT syndrome; QT; Risperidone; Selective acquired long QT syndrome

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; ESCITALOPRAM; HALOPERIDOL; RISPERIDONE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG SAFETY; DRUG SELECTIVITY; FEMALE; GENE; GENE MUTATION; HUMAN; KCNE1 GENE; KCNE2 GENE; KCNH2 GENE; KCNQ1 GENE; LONG QT SYNDROME; MUTATIONAL ANALYSIS; QT INTERVAL; QT PROLONGATION; RISK FACTOR; SCHIZOPHRENIA; SCN5A GENE; SELECTIVE ACQUIRED LONG QT SYNDROME; CARDIOVASCULAR RISK; DOSE RESPONSE; ELECTROCARDIOGRAM; GENETIC ANALYSIS; OBSERVATIONAL STUDY;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; POTASSIUM CHANNELS; RISPERIDONE; SCHIZOPHRENIA;

EID: 84870317865     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-220     Document Type: Article

References (15)

1. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803. 10.1016/0092-8674(95)90358-5, 7889573.
2. Kannankeril P, Roden DM, Darbar D. Drug-induced long QT syndrome. Pharmacol Rev 2010, 62:760-781. 10.1124/pr.110.003723, 2993258, 21079043.
3. Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 2003, 45:415-427.
4. Stöllberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol 2005, 20:243-251. 10.1097/01.yic.0000166405.49473.70, 16096514.
5. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005, 115:2025-2032. 10.1172/JCI25539, 1180553, 16075043.
6. Saenen JB, Vrints CJ. Molecular aspects of the congenital and acquired Long QT Syndrome: clinical implications. Mol Cell Cardiol 2008, 44:633-646.
7. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med (Berl) 2004, 82:182-188.
8. Suzuki Y, Fukui N, Watanabe J, Ono S, Sugai T, Tsuneyama N, Saito M, Inoue Y, Someya T. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Hum Psychopharmacol 2012, 27:39-42. 10.1002/hup.1258, 22144033.
9. Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics. Psychopharmacology (Berl) 2011, 216:9-16.
10. Nishio Y, Makiyama T, Itoh H, et al. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol 2009, 54:812-819. 10.1016/j.jacc.2009.06.005, 19695459.
11. Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, Tichet J, Tiret L, Balkau B, Guicheney P. Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 2007, 15:974-979. 10.1038/sj.ejhg.5201866, 2234597, 17534376.
12. Tristani-Firouzi, Sanguinetti MC. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol 2003, 35:27-35. 10.1016/S0022-2828(02)00286-9, 12623297.
13. Hayashi K, Shuai W, Sakamoto Y, Higashida H, Yamagishi M, Kupershmidt S. Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Heart Rhythm 2010, 7:973-980. 10.1016/j.hrthm.2010.03.038, 2904856, 20348026.
14. Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 2004, 24:62-69. 10.1097/01.jcp.0000104913.75206.62, 14709949.
15. Hedley PL, Jørgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink PA, Kanters JK, Corfield VA, Christiansen M. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009, 30:1486-1511. 10.1002/humu.21106, 19862833.